Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Matthew J, Kapalis"'
Autor:
Akshay K. Mahadevia, Gautum Reddy, Nicolas W. Shammas, Dawn McKinney, Jon H. Lemke, Eric J. Dippel, Matthew J Kapalis, Harb Harb, Moutasim H. Al-Shaer
Publikováno v:
International Journal of Angiology. 14:129-132
Obstructive sleep apnea (OSA) is associated with an increase in high-sensitivity C-reactive protein (hs-CRP). Studies suggested that the degree of severity of OSA in obese patients with no known coronary artery disease correlates with higher levels o
Autor:
Eric J. Dippel, Mythri Reddy, Michael Jerin, Nicolas W. Shammas, Harb Harb, Matthew J Kapalis, Peter P. Toth
Publikováno v:
Preventive Cardiology. 11:95-99
Severe graft disease occurs in patients at a rate of approximately 15% within the first year of coronary artery bypass grafting (CABG). In this study, the authors examined predictors of the combined end point of death, nonfatal myocardial infarction
Autor:
Nicolas W, Shammas, Eric J, Dippel, Jon H, Lemke, Jon, Robken, H Lester, Kirchner, Vickie, Takes, Matthew J, Kapalis, Theresa, Palabrica
Publikováno v:
The Journal of invasive cardiology. 18(1)
An acute inflammatory response occurs following percutaneous coronary and peripheral vascular interventions (PVI), partly mediated by platelet activation. Glycoprotein (GP) IIb-IIIa inhibitors might partially attenuate this inflammation rise in the c
Autor:
Pragnesh, Patel, Nicolas W, Shammas, Matthew J, Kapalis, Eric J, Dippel, Jon, Lemke, Catherine, Harb
Publikováno v:
The Journal of invasive cardiology. 17(9)
The left internal mammary (LIMA) is an ideal conduit for bypassing the left anterior descending artery (LAD) during coronary artery bypass surgery (CABG). In this study, we evaluate the frequency of significant disease in the LIMA prior to CABG and d
Autor:
Nicolas W, Shammas, Matthew J, Kapalis, Eric J, Dippel, Michael J, Jerin, Jon H, Lemke, Pragnesh, Patel, Melodee, Harris
Publikováno v:
The Journal of invasive cardiology. 16(1)
Percutaneous stenting has become the procedure of choice for treatment of obstructive atherosclerotic renal artery (RA) disease. Restenosis, however, continues to be in the range of 15-25% of treated vessels. In this study, clinical and angiographic